Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 30, 2026
CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 20, 2026
High Incidence of Cytomegalovirus Infection in Patients Receiving Standard of Care CD19- or BCMA-Targeted CAR-T Cell Therapies for Hematologic Malignancies.
Journal: Transplantation and cellular therapy
Published: December 08, 2025
Impact of Complete Response on Long-Term Survival in Patients with Relapsed or Refractory Large B-cell Lymphoma: A Center for International Blood and Marrow Transplant Research Prospective Study and Systematic Literature Review/Meta-Analysis.
Journal: Transplantation and cellular therapy
Published: August 12, 2025
The evolving treatment paradigm of chimeric antigen receptor T-cell therapy in lymphoma.
Journal: Current opinion in oncology
Published: July 07, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis.
Journal: American journal of cancer research
Published: May 19, 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration.
Journal: Blood advances
Published: May 15, 2025
Outpatient Brexucabtagene Autoleucel in B-Cell Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma.
Journal: American journal of hematology
Published: April 09, 2025
Last Updated: 09/26/2026